Pentostatin Cyclophosphamide And Rituximab (PCR) For B-Cell Chronic Lymphocytic Leukemia (CLL) And Small B-Cell Lymphocytic Lymphoma (SLL): Four Phase II Trials With Patient Stratification Based On Prior Therapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Pentostatin (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia; Lymphoma
- Focus Therapeutic Use
- 12 May 2011 Biomarkers information updated
- 11 May 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.